These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1135 related articles for article (PubMed ID: 26708045)

  • 1. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
    Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
    Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Pathologically Positive Lymph Nodes in the Clinically Negative Neck: An Analysis of 39,301 Patients with Papillary Thyroid Cancer.
    Ruel E; Thomas S; Perkins JM; Roman SA; Sosa JA
    Ann Surg Oncol; 2017 Jul; 24(7):1935-1942. PubMed ID: 28127652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central Lymph Node Status has Significant Prognostic Value in the Clinically Node-Negative Tall-Cell Variant of Papillary Thyroid Cancer Regardless of T-Staging and Radioactive Iodine Administration: First Evidence From a Population-Based Study.
    Shi X; Huang NS; Lei BW; Song KH; Shi RL; Wei WJ; Hu WP; Dong F; Wang Y; Wang YL; Ji QH
    Ann Surg Oncol; 2018 Aug; 25(8):2316-2322. PubMed ID: 29845406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical response to radioactive iodine therapy for prophylactic central neck dissection is not superior to total thyroidectomy alone in cN0 patients with papillary thyroid cancer.
    Lin B; Qiang W; Wenqi Z; Tianyu Y; Lina Z; Bin J
    Nucl Med Commun; 2017 Dec; 38(12):1036-1040. PubMed ID: 28953211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of Adjuvant Radioactive Iodine Therapy Does Not Affect Overall Survival in Low- and Intermediate-Risk Papillary Thyroid Carcinoma.
    Suman P; Wang CH; Moo-Young TA; Prinz RA; Winchester DJ
    Am Surg; 2016 Sep; 82(9):807-14. PubMed ID: 27670568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Central Neck Lymph Node Metastases in Micro- Versus Macro- Clinically Node Negative Papillary Thyroid Carcinoma.
    Sessa L; Lombardi CP; De Crea C; Tempera SE; Bellantone R; Raffaelli M
    World J Surg; 2018 Mar; 42(3):623-629. PubMed ID: 29238850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
    Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
    Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of postoperative radioactive iodine scans in patients who underwent prophylactic central lymph node dissection.
    Laird AM; Gauger PG; Miller BS; Doherty GM
    World J Surg; 2012 Jun; 36(6):1268-73. PubMed ID: 22270997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer.
    Ruel E; Thomas S; Dinan M; Perkins JM; Roman SA; Sosa JA
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1529-36. PubMed ID: 25642591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIMING OF RADIOACTIVE IODINE THERAPY DOES NOT IMPACT OVERALL SURVIVAL IN HIGH-RISK PAPILLARY THYROID CARCINOMA.
    Suman P; Wang CH; Abadin SS; Block R; Raghavan V; Moo-Young TA; Prinz RA; Winchester DJ
    Endocr Pract; 2016 Jul; 22(7):822-31. PubMed ID: 27018620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lateral neck lymph node metastasis in cN0 papillary thyroid carcinoma].
    Chen R; Wei T; Zhang M; Li JQ; Zou XH; Fu BH; Wang LP; Peng YL; Ma BY; Zhu JQ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 47(8):662-7. PubMed ID: 23141398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
    Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and meta-analysis of prophylactic central neck dissection on short-term locoregional recurrence in papillary thyroid carcinoma after total thyroidectomy.
    Lang BH; Ng SH; Lau LL; Cowling BJ; Wong KP; Wan KY
    Thyroid; 2013 Sep; 23(9):1087-98. PubMed ID: 23402640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic Central Neck Dissection in Papillary Thyroid Carcinoma: All Risks, No Reward.
    Dismukes J; Fazendin J; Obiarinze R; Márquez GCH; Ramonell KM; Buczek E; Lindeman B; Chen H
    J Surg Res; 2021 Aug; 264():230-235. PubMed ID: 33838407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer.
    Robinson TJ; Thomas S; Dinan MA; Roman S; Sosa JA; Hyslop T
    J Clin Oncol; 2016 Oct; 34(28):3434-9. PubMed ID: 27528716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
    Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
    Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of radionuclide therapy for the residue after surgery in papillary thyroid carcinoma].
    Wu Y; Zheng R; Luo D; Yang H; Liang Q
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jun; 50(6):497-501. PubMed ID: 26695803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the patterns of cervical lymph node recurrence in patients with cN0 papillary thyroid carcinoma after central neck lymph node dissection].
    Huang H; Xu Z; Wang X; Wu Y; Liu S
    Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):771-5. PubMed ID: 26813598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.